Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy M Holekamp

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Ophthalmic Surgery, Lasers & Imaging Retina|April 21, 2016
Forming a Consensus: Data and Guidance for Physicians Treating Diabetic Macular EdemaCarmen A Puliafito, Scott W Cousins, Jason Bacharach, et al.
Ophthalmology. Retina|June 24, 2024
Supplemental Intravitreal Ranibizumab Injections in Eyes Treated with the Port Delivery System with Ranibizumab in the Archway TrialJared S Nielsen, Andrew Chang, Nancy M Holekamp, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|January 12, 2005
Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreousSeenu M Hariprasad, Kevin J Blinder, Gaurav K Shah, et al.
American Journal of Ophthalmology|September 21, 2016
Early and Long-Term Responses to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema: Analysis of Protocol I DataVictor H Gonzalez, Joanna Campbell, Nancy M Holekamp, et al.
Eye (London, England)|July 20, 2019
Relationship between duration and extent of oedema and visual acuity outcome with ranibizumab in diabetic macular oedema: A post hoc analysis of Protocol I dataSrinivas R Sadda, Joanna Campbell, Pravin U Dugel, et al.
American Journal of Ophthalmology|March 27, 2017
ReplyVictor H Gonzalez, Joanna Campbell, Nancy M Holekamp, et al.
Patient Preference and Adherence|March 10, 2022
Drivers of and Barriers to Adherence to Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema Treatment Management Plans: A Multi-National Qualitative StudyAudrey Giocanti-Aurégan, Alfredo García-Layana, Tunde Peto, et al.
Retina (Philadelphia, Pa.)|February 24, 2018
ASSOCIATION BETWEEN EARLY ANATOMIC RESPONSE TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY AND LONG-TERM OUTCOME IN DIABETIC MACULAR EDEMA: An Independent Analysis of Protocol i Study DataPravin U Dugel, Joanna H Campbell, Szilárd Kiss, et al.
Ophthalmic Research|August 29, 2024
Caregiver Experience Survey of Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema and Neovascular Age-Related Macular DegenerationFrancesco Viola, Gloria C Chi, Nancy M Holekamp, et al.
Ophthalmology|November 4, 2004
Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: ophthalmic findings: SST report no. 11Barbara S Hawkins, Neil M Bressler, Päivi H Miskala, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Ophthalmic Surgery, Lasers & Imaging Retina|April 21, 2016
Forming a Consensus: Data and Guidance for Physicians Treating Diabetic Macular EdemaCarmen A Puliafito, Scott W Cousins, Jason Bacharach, et al.
Ophthalmology. Retina|June 24, 2024
Supplemental Intravitreal Ranibizumab Injections in Eyes Treated with the Port Delivery System with Ranibizumab in the Archway TrialJared S Nielsen, Andrew Chang, Nancy M Holekamp, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|January 12, 2005
Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreousSeenu M Hariprasad, Kevin J Blinder, Gaurav K Shah, et al.
American Journal of Ophthalmology|September 21, 2016
Early and Long-Term Responses to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema: Analysis of Protocol I DataVictor H Gonzalez, Joanna Campbell, Nancy M Holekamp, et al.
Eye (London, England)|July 20, 2019
Relationship between duration and extent of oedema and visual acuity outcome with ranibizumab in diabetic macular oedema: A post hoc analysis of Protocol I dataSrinivas R Sadda, Joanna Campbell, Pravin U Dugel, et al.
American Journal of Ophthalmology|March 27, 2017
ReplyVictor H Gonzalez, Joanna Campbell, Nancy M Holekamp, et al.
Patient Preference and Adherence|March 10, 2022
Drivers of and Barriers to Adherence to Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema Treatment Management Plans: A Multi-National Qualitative StudyAudrey Giocanti-Aurégan, Alfredo García-Layana, Tunde Peto, et al.
Retina (Philadelphia, Pa.)|February 24, 2018
ASSOCIATION BETWEEN EARLY ANATOMIC RESPONSE TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY AND LONG-TERM OUTCOME IN DIABETIC MACULAR EDEMA: An Independent Analysis of Protocol i Study DataPravin U Dugel, Joanna H Campbell, Szilárd Kiss, et al.
Ophthalmic Research|August 29, 2024
Caregiver Experience Survey of Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema and Neovascular Age-Related Macular DegenerationFrancesco Viola, Gloria C Chi, Nancy M Holekamp, et al.
Ophthalmology|November 4, 2004
Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: ophthalmic findings: SST report no. 11Barbara S Hawkins, Neil M Bressler, Päivi H Miskala, et al.
Pageof 7